MAAT PHARMA

MAAT
Real-time Euronext Paris - 11:09 2022-12-01 am EST
9.100 EUR +3.41%

Turn to zoom
Prev.9.10000000
Open9.00000000
High9.10000000
Low8.98000000
Volume805
Latest news
1d ago
11/09
11/03
10/05
Chart MAAT PHARMA
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance9,229,9010,4
Spread/Res.-1,3%-8,1%-13%
Spread/Supp.7,1%23%12%
Support8,507,408,16
Financials
Sales 2022 2,00 M 2,06 M 2,06 M
Net income 2022 - - -
Net cash 2022 16,2 M 16,7 M 16,7 M
P/E ratio 2022 -6,96x
Yield 2022 -
Capitalization 87,1 M 89,8 M 89,8 M
EV / Sales 2022 35,4x
EV / Sales 2023 47,9x
Nbr of Employees 37
Free-Float 65,1%
Company
MaaT Pharma is specialized in the research and development of microbiome biotherapies for use in the treatment of solid cancer tumors.
The company has a portfolio of 2 products in clinical development, including 1 in Phase II (MaaT013 for the treatment of acute graft-versus-host disease) and 1 in...
Sector :
Other Pharmaceuticals
Calendar :
2022-12-10 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 8,80 €
Average target price 19,30 €
Spread / Average Target 119%